S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
Bear Market Expert Reveals His #1 Stock for November 2023  (Ad)pixel
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
🚨 [Strong Buy Alert] Is this laser stock in your portfolio? (Ad)
Microsoft strikes 10-year deal with Nintendo on Call of Duty
Could trawler cams help save world's dwindling fish stocks?
🚨 [Strong Buy Alert] Is this laser stock in your portfolio? (Ad)
Southwest Airlines brings back dividend as travel rebounds
Closing prices for crude oil, gold and other commodities
S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
Bear Market Expert Reveals His #1 Stock for November 2023  (Ad)pixel
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
🚨 [Strong Buy Alert] Is this laser stock in your portfolio? (Ad)
Microsoft strikes 10-year deal with Nintendo on Call of Duty
Could trawler cams help save world's dwindling fish stocks?
🚨 [Strong Buy Alert] Is this laser stock in your portfolio? (Ad)
Southwest Airlines brings back dividend as travel rebounds
Closing prices for crude oil, gold and other commodities
S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
Bear Market Expert Reveals His #1 Stock for November 2023  (Ad)pixel
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
🚨 [Strong Buy Alert] Is this laser stock in your portfolio? (Ad)
Microsoft strikes 10-year deal with Nintendo on Call of Duty
Could trawler cams help save world's dwindling fish stocks?
🚨 [Strong Buy Alert] Is this laser stock in your portfolio? (Ad)
Southwest Airlines brings back dividend as travel rebounds
Closing prices for crude oil, gold and other commodities
S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
Bear Market Expert Reveals His #1 Stock for November 2023  (Ad)pixel
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
🚨 [Strong Buy Alert] Is this laser stock in your portfolio? (Ad)
Microsoft strikes 10-year deal with Nintendo on Call of Duty
Could trawler cams help save world's dwindling fish stocks?
🚨 [Strong Buy Alert] Is this laser stock in your portfolio? (Ad)
Southwest Airlines brings back dividend as travel rebounds
Closing prices for crude oil, gold and other commodities
NYSE:AVTR

Avantor - AVTR Price Target & Analyst Ratings

$21.81
+0.20 (+0.93%)
(As of 12/7/2022 12:00 AM ET)
Add
Compare
Today's Range
$21.52
$22.08
50-Day Range
$19.22
$22.80
52-Week Range
$17.91
$42.48
Volume
6.44 million shs
Average Volume
5.70 million shs
Market Capitalization
$14.70 billion
P/E Ratio
23.20
Dividend Yield
N/A
Price Target
$28.93

Avantor Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 13 Analyst Ratings

Consensus Analyst Price Target

$28.93
32.64% Upside
High Prediction$40.00
Average Prediction$28.93
Low Prediction$23.00
TypeCurrent
12/8/21 to 12/8/22
1 Month Ago
11/8/21 to 11/8/22
3 Months Ago
9/9/21 to 9/9/22
1 Year Ago
12/8/20 to 12/8/21
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
10 Buy rating(s)
11 Buy rating(s)
12 Buy rating(s)
14 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
2 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$28.93$28.93$37.62$45.20
Predicted Upside32.64% Upside35.58% Upside19.81% Upside15.76% Upside
Get Avantor Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for AVTR and its competitors with MarketBeat's FREE daily newsletter.


AVTR Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

AVTR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Avantor Stock vs. The Competition

TypeAvantorMedical CompaniesS&P 500
Consensus Rating Score
2.77
2.66
2.48
Consensus RatingModerate BuyBuyHold
Predicted Upside32.64% Upside595.30% Upside15.58% Upside
News Sentiment RatingNeutral News
Neutral News
Neutral News
MarketBeat
Community Rating
Outperform Votes
143
65.30%
Underperform Votes
76
34.70%
Avg. Outperform Votes
163
66.26%
Avg. Underperform Votes
83
33.74%
Avg. Outperform Votes
853
68.13%
Avg. Underperform Votes
399
31.87%

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/4/2022UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$33.00+64.51%
11/1/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$26.00+30.13%
10/31/2022Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$27.00 ➝ $26.00+31.85%
10/31/2022Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$30.00 ➝ $28.00+40.28%
10/31/2022Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$28.00 ➝ $25.00+30.07%
10/31/2022Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$32.00 ➝ $29.00+50.88%
10/31/2022Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$33.00 ➝ $27.00+40.48%
10/31/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral$32.00 ➝ $25.00+30.07%
10/31/2022Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$25.00 ➝ $23.00+19.67%
10/13/2022The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$37.00 ➝ $32.00+64.78%
9/19/2022Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$35.00 ➝ $28.00+24.56%
9/15/2022KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$51.00 ➝ $40.00+70.50%
8/9/2022Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$35.00+25.13%
4/29/2022William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
B. Weinstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
11/22/2021JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOverweight
8/2/2021Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$35.00 ➝ $45.00+18.45%
8/2/2021Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Overweight$40.00 ➝ $45.00+19.74%
12/16/2020Smith Barney Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$28.00 ➝ $33.00+19.18%
10/9/2020Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$25.00 ➝ $30.00+23.46%
4/30/2020CSFB
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$20.00 ➝ $18.00+7.08%
(Data available from 12/8/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












AVTR Price Target - Frequently Asked Questions

What is Avantor's consensus rating and price target?

According to the issued ratings of 13 analysts in the last year, the consensus rating for Avantor stock is Moderate Buy based on the current 3 hold ratings and 10 buy ratings for AVTR. The average twelve-month price prediction for Avantor is $28.93 with a high price target of $40.00 and a low price target of $23.00. Learn more on AVTR's analyst rating history.

Do Wall Street analysts like Avantor more than its competitors?

Analysts like Avantor more than other Medical companies. The consensus rating for Avantor is Moderate Buy while the average consensus rating for medical companies is Buy. Learn more on how AVTR compares to other companies.

Do MarketBeat users like Avantor more than its competitors?

MarketBeat users like Avantor less than other Medical companies. 65.30% of MarketBeat users gave Avantor an outperform vote while medical companies recieve an average of 66.40% outperform votes by MarketBeat users.

Is Avantor being upgraded or downgraded by Wall Street analysts?

Over the previous 90 days, Avantor's stock had 2 downgrades and 1 upgrade by analysts.

Does Avantor's stock price have much upside?

According to analysts, Avantor's stock has a predicted upside of 35.58% based on their 12-month price targets.


Stock Ratings Reports and Tools

This page (NYSE:AVTR) was last updated on 12/8/2022 by MarketBeat.com Staff